Post by Altek Corporation

【榮晶醫療邁向綠色醫療新里程：正式通過 SBTi  目標設定審查！】 華晶集團很榮幸宣布，子公司榮晶醫療提出的溫室氣體減量短期目標，已正式獲得 SBTi（科學基礎減碳目標倡議）的官方認可！ 這不僅是對我們永續發展承諾的肯定，更標誌著我們在追求醫療器材創新（CDMO）的同時，已將環境守護納入企業的核心競爭力。 【榮晶目標（2030年）】： 範疇一(直接排放)與範疇二(能源間接排放)：達成42%的絕對減量。 範疇三(其他間接排放)：排放量減少25%。 供應商協作：攜手60%的合作供應商共同參與 SBTi目標設定。 為了落實這項指標，我們將全面推動製程節能優化，並逐步提高再生能源的使用比例，確保在維持精密製造高品質的前提下，有效降低排碳量。 醫材產業的低碳轉型需要價值鏈夥伴的共同投入。我們期待與全球客戶及供應商緊密協作，共同打造更具韌性的綠色醫療供應鏈！ 主題標籤 #AltekMedical #榮晶醫療 #SBTi #ESG #Sustainability #MedicalDevice #CDMO #ClimateAction #GreenManufacturing #永續發展 【Milestone: Altek Medical’s GHG Emission Targets Validated by SBTi】 We are proud to announce that Altek Medical’s near-term greenhouse gas (GHG) emission reduction targets have been officially approved by the Science Based Targets initiative (SBTi). This marks a major step in integrating sustainability into our core CDMO competitiveness. 【Our 2030 Commitment】: Scope 1 (Direct Emission) & 2 (Indirect Emission): 42% absolute reduction. Scope 3 (Other Indirect Emission): 25% emissions reduction. Supplier Engagement: 60% of suppliers to set SBTi-aligned targets. By optimizing manufacturing efficiency and transitioning to renewable energy, we ensure that high-precision production meets low-carbon standards. We look forward to collaborating with our global partners to build a resilient, green healthcare supply chain. 主題標籤 #AltekMedical #SBT #ESG #Sustainability #MedicalDevice #CDMO #ClimateAction #GreenManufacturing #SustainableDevelopment